All Access Articles |
- Biocryst Reports 38% Revenue Increase in 2025 | 2026-02-26 | UNITED STATES
- Biocryst Pharmaceuticals Acquires Astria Therapeutics, Solidifying HAE Treatment Leadership | 2026-01-25 | UNITED STATES
- FDA Accepts Biocryst's NDA for Pediatric HAE Drug | 2025-05-14 | BIOTECHNOLOGY
- BioCryst Pharmaceuticals Reports Strong Revenue Growth | 2024-02-26 | BIOTECHNOLOGY